Avisio signs agreement to commercialize Instant Detect diagnostic technology

Avisio, Inc. (PINKSHEETS: AVIC) announces the signing of a definitive agreement to commercialize Instant Detect, a portable nano-based diagnostic technology. Avisio, a publicly-traded commercialization company with a mission to unlock the value of high-potential assets and transform them into high-value businesses, now has the worldwide license to commercialize Instant Detect's ground-breaking portable diagnostic sensory technology. With the agreement, Avisio has exclusive acquisition rights for 18 months.

Instant Detect's sensory technology will be incorporated into a highly sensitive handheld instrument designed for use in the field. Using nanosensors, the technology allows for the testing of viruses, bacteria and other disease-causing pathogens in a non-laboratory environment, with immediately available results that do not require the expertise of a specialized lab technician to read.

Among potential uses envisioned for the technology, professional individuals will ultimately be able to instantly detect such disease-causing pathogens as H1N1, West Nile Virus, dengue, malaria and encephalitis among at risk populations, while agricultural inspectors will be able to detect pathogens in the food supply and farmers will be able to detect plant diseases and livestock pathogens instantly. The device will require no specialized training and can detect pathogens from a broad range of samples.

Avisio intends to make the product commercially available in the second half of 2010.

SOURCE: Avisio, Inc.